Clinical Trial Update: Rt-PA in the Treatment of Acute Ischemic Stroke [Phase 3]

View source ↗

Summary

Phase 3 trial of recombinant tissue plasminogen activator (rt-PA) for acute ischemic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Activase (alteplase) (alteplase)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Cerebrovascular Accident | Phase 3 | Status: COMPLETED